Navigation Links
UCLA scientist awarded $3 million to fund research into proteins affecting the kidney
Date:4/1/2014

UCLA Scientist Dr. Ira Kurtz has received a $3 million gift from the Donald T. Sterling Foundation to fund research on the structural properties of key proteins in the kidney that affect its function in health and disease. His ultimate aim is the discovery of new molecular approaches, which will aid in the development of drugs to treat patients with various kidney disorders.

"This gift will play a key role in accelerating the success of ongoing research projects in my lab," said Kurtz, a professor of medicine, who holds the Factor Chair in nephrology and serves as chief of the division of nephrology at UCLA. "There is currently a worldwide epidemic of kidney disease today. More than 500 million people worldwide have some form of kidney damage. Millions of people are affected and die each year, and a disproportionate number in the Unites States are African Americans, Latinos and other minorities."

A major goal of Kurtz's basic research program is to understand the fundamental biological processes affecting kidney function at the molecular level. One of the focuses of his lab is to unravel the atomic structure of various proteins in the kidney that contribute to kidney disease.

The proteins he studies reside either in the plasma membrane surrounding the cell, called membrane proteins, or are located inside the cell in the cytoplasm, called soluble proteins. He and his team utilize a range of methodologies, including x-ray crystallography, biochemical, cell and molecular biology, and genetic approaches to understand the structure and functional properties of kidney proteins.

By closely studying the structure of both membrane and soluble kidney proteins, Kurtz and his team hope to be able to design new therapeutics that target specific disease-causing proteins, while leaving other normal proteins unaffected.

"Determining the structure of these disease-causing proteins is vital for designing very specific drugs," he said. "If we are successful, we have the great benefit of being able to use much lower doses of a particular drug, which is very beneficial to patients, since side effects and unwanted symptoms are significantly reduced."

In the United States alone, more than 25 million people suffer from some degree of kidney function impairment, and more than 600,000 patients are on dialysis or have received a kidney transplant at a cost of more than $32 billion annually to taxpayers, Kurtz said.


'/>"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-794-2262
University of California - Los Angeles Health Sciences
Source:Eurekalert  

Related biology news :

1. Behind the scenes of the IPCC report, with Stanford scientists
2. Scripps Florida scientists offer best practices nutrition measurement for researchers
3. Notre Dame scientists develop largest developmental proteomic data set for any animal
4. Research from CHORI scientists demonstrates first genome methylation in fruit fly
5. Harvard scientists visualize new treatments for retinal blindness
6. ASU scientist Roy Curtiss receives Lifetime Achievement Award from ASM
7. A*STAR scientists create stem cells from a drop of blood
8. Freiburg scientist is awarded the Paul Ehrlich and Ludwig Darmstaedter Prize
9. Plant biology discovery furthers scientists understanding of plant growth and development
10. Tropical grassy ecosystems under threat, scientists warn
11. Scientists herd cells in new approach to tissue engineering
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UCLA scientist awarded $3 million to fund research into proteins affecting the kidney
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... DIEGO , June 22, 2016 ... that will allow them to produce up to ... from one lot within one week. These high-quality, ... time laboriously preparing cells and spend more time ... possible through a proprietary, high-volume manufacturing process that ...
Breaking Biology Technology: